Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma

[1]  L. Leoncini,et al.  MYC translocation‐negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation , 2008, The Journal of pathology.

[2]  R. Siebert,et al.  Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.

[3]  S. Barrans,et al.  A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). , 2008, Blood.

[4]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[5]  W. Klapper,et al.  High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma , 2007, Leukemia.

[6]  R. Gascoyne,et al.  Expression of TRAF1 and Nuclear c-Rel Distinguishes Primary Mediastinal Large Cell Lymphoma From Other Types of Diffuse Large B-cell Lymphoma , 2007, The American journal of surgical pathology.

[7]  E. Schuuring,et al.  Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[9]  Richard Simon,et al.  Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.

[10]  K. Savage.  Primary mediastinal large B-cell lymphoma. , 2006, The oncologist.

[11]  T. Mattfeldt,et al.  Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation , 2006, Oncogene.

[12]  T. Habermann,et al.  Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior , 2005, The American journal of surgical pathology.

[13]  P. Gaulard,et al.  Mediastinal Gray Zone Lymphoma: The Missing Link Between Classic Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma , 2005, The American journal of surgical pathology.

[14]  T. Golub,et al.  NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. , 2005, Blood.

[15]  H. Müller-Hermelink,et al.  Clinical, Immunophenotypic, and Genetic Analysis of Adult Lymphomas With Morphologic Features of Burkitt Lymphoma , 2005, The American journal of surgical pathology.

[16]  J. Forteza,et al.  Large B‐cell lymphoma with Hodgkin's features , 2005, Histopathology.

[17]  R. Gascoyne,et al.  Aggressive B‐cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology , 2005, Histopathology.

[18]  M. Calaminici,et al.  CD23 expression in mediastinal large B‐cell lymphomas , 2004, Histopathology.

[19]  T. Barth,et al.  [Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line]. , 2004, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[20]  E. Jaffe,et al.  Molecular Profiling Provides Evidence of Primary Mediastinal Large B-Cell Lymphoma as a Distinct Entity Related to Classic Hodgkin Lymphoma: Implications for Mediastinal Gray Zone Lymphomas as an Intermediate Form of B-Cell Lymphoma , 2004, Advances in anatomic pathology.

[21]  Karen Leroy,et al.  Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. , 2004, Blood.

[22]  T. Golub,et al.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. , 2003, Blood.

[23]  L. Staudt,et al.  Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma , 2003, The Journal of experimental medicine.

[24]  C. Copie-Bergman,et al.  Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. , 2003, Blood.

[25]  R. Siebert,et al.  Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2 , 2003, International journal of cancer.

[26]  C. Copie-Bergman,et al.  MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell Lymphomas , 2002, Modern Pathology.

[27]  R. Bataille,et al.  Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. , 2001, Blood.

[28]  N. Harris,et al.  Expression of bcl-6 and CD10 in Primary Mediastinal Large B-Cell Lymphoma: Evidence for Derivation From Germinal Center B Cells? , 2001, The American journal of surgical pathology.

[29]  P. Isaacson,et al.  CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. , 2000, The American journal of surgical pathology.

[30]  J. Cigudosa,et al.  Cytogenetic analysis of 363 consecutively ascertained diffuse large B‐cell lymphomas , 1999, Genes, chromosomes & cancer.

[31]  R. Gascoyne,et al.  Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  P. Gaulard,et al.  Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. , 1996, The American journal of surgical pathology.

[33]  K. Sano,et al.  Coexpression of cell-surface immunoglobulin (sIg), terminal deoxynucleotidyl transferase (TdT) and recombination activating gene 1 (RAG-1): two cases and derived cell lines. , 1996, Leukemia.

[34]  P. Lichter,et al.  Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. , 1996, Blood.

[35]  A. Aisenberg.  Primary large cell lymphoma of the mediastinum. , 1993, Seminars in oncology.

[36]  O. Olopade,et al.  Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11) , 1990, Genes, chromosomes & cancer.

[37]  N. Harris,et al.  Primary Large Cell Lymphoma of the Mediastinum: A Histologic and Immunophenotypic Study of 29 Cases , 1989, The American journal of surgical pathology.

[38]  N. Harris,et al.  Mediastinal large cell lymphoma: An uncommon subset of adult lymphoma curable with combined modality therapy , 1988, Cancer.

[39]  P. Isaacson,et al.  Large cell lymphoma of the mediastinum: a B‐cell tumour of probable thymic origin , 1986, Histopathology.

[40]  H. Kohlhammer,et al.  Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH) , 2007, Leukemia.

[41]  L. Medeiros,et al.  Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis , 2006, Modern Pathology.

[42]  P. Gaulard,et al.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. , 2003, The American journal of pathology.

[43]  R. Gascoyne,et al.  Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.